ORASURE TECHNOLOGIES, INC Cash and Restricted Cash
ORASURE TECHNOLOGIES, INC (OSUR) had Cash and Restricted Cash of $64.06 million as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2018-05-09
- 2018-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $64.06M.
- 2017-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $72.87M.
- 2017-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78.61M.
- 2017-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $106.70M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2018-03-31 | $64.06M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $72.87M 10-Q · filed 2018-05-09 | |
| 2017-09-30 | $78.61M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $106.70M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $120.85M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $107.96M 10-Q · filed 2018-05-09 | $109.79M 10-Q · filed 2017-08-09 |
| 2016-09-30 | $113.54M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $105.70M 10-Q · filed 2017-08-09 | |
| 2015-12-31 | $94.09M 10-K · filed 2018-02-28 | |
| 2014-12-31 | $92.87M 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |